As of September 24, 2026, the Company had approximately 1,463,958 shares of Common Stock issued and outstanding.
As of September 24, 2026, the Company had approximately 1,463,958 shares of Common Stock issued and outstanding.
As of September 23, 2026, the Company had approximately 1,281,867 shares of Common Stock issued and outstanding.
As of September 23, 2026, the Company had approximately 1,281,867 shares of Common Stock issued and outstanding.
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...